07.24.25 -- Preparing For FDA's Expanded Use Of Unannounced Inspections At Foreign Manufacturing Facilities

Boundless automation reimagines industrial computing through seamless integration of the intelligent field, edge, and cloud, unified by a real-time data fabric that enables digital transformation.

From minimizing costs and accessing advanced tech to speeding market entry, dive into how outsourcing drug development and manufacturing to CMOs/CDMOs offers strategic advantages.

The panel explores what the next generation of digital technology will look and feel like from users’ perspective. Hear from experts at Microsoft, GSK, TetraScience, Emerson and IDBS.

Discover how to build a realistic budget for digital validation with ten essential steps to align costs with goals, secure stakeholder buy-in, and ensure a successful implementation.

Walk through the rigorous inspection process pharmaceutical products undergo to ensure safety and quality, from granulated ingredients to packaging.

The approaches exist to safely test small-molecule antivirals, large-molecule biologics, and vaccines — moving development of RSV vaccines and anti-viral drugs in an exciting direction.

Learn why the trends in packaging of prescription and over-the-counter drugs indicate continued growth in the blister packaging market. 

See how applying lyophilization-based micronization methodology at a small scale helps to support challenging formulation development projects.

Strategic partnerships can streamline your transition from Phase 1 to Phase 2 clinical studies, ensuring optimized dosage forms, seamless scale-up, and alignment with patient and study requirements.

Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.

Examine challenges and key considerations for spray-dried formulations for inhalation, along with a review of current technologies and approved products utilizing particle engineering approaches.

Asher Biotherapeutics was seeking a CDMO that could handle Phase 2 through to commercial production, as well as taking early-stage projects in its pipeline all the way through their lifecycle.

Uncover the advantages of digitalizing Continued Process Verification (CPV) through the experience of a pharmaceutical company step-by-step.

Gain insight into the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.